4.7 Letter

Heat shock factor 1 is a potent therapeutic target for enhancing the efficacy of treatments for multiple myeloma with adverse prognosis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Hematology

The heat shock transcription factor 1 as a potential new therapeutic target in multiple myeloma

Tanja Heimberger et al.

BRITISH JOURNAL OF HAEMATOLOGY (2013)

Article Oncology

Cell Death via DR5, but not DR4, Is Regulated by p53 in Myeloma Cells

Sylvanie Surget et al.

CANCER RESEARCH (2012)

Review Oncology

Novel Targets and Derived Small Molecule Inhibitors in Multiple Myeloma

Klaus Podar

CURRENT CANCER DRUG TARGETS (2012)

Review Oncology

Latest advances and current challenges in the treatment of multiple myeloma

Anuj Mahindra et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2012)

Article Hematology

The molecular classification of multiple myeloma

Fenghuang Zhan et al.

Article Hematology

Antimyeloma activity of heat shock protein-90 inhibition

CS Mitsiades et al.